Insider Trading: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

101.08USD
24 Apr 2015
Change (% chg)

$0.62 (+0.62%)
Prev Close
$100.46
Open
$100.07
Day's High
$101.52
Day's Low
$100.00
Volume
2,056,909
Avg. Vol
2,567,714
52-wk High
$109.49
52-wk Low
$95.10

Search Stocks
ULLMANN MICHAEL H Options Exercised: 0
Trade Date: Sunday, 4 Aug 2013 Price: 93.68
Title: General Counsel Shares Held: 56,794
Type Traded: Direct Net Change in Shares This Filing: 4,531

Institutional Holders

% Shares Owned: 67.51%
# of Holders: 2,644
Total Shares Held: 1,877,163,043
3 Mo. Net Change: 1,547,709
# New Positions: 13
# Closed Positions: 22
# Increased Positions: 246
# Reduced Positions: 246
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

Alex Gorsky

54 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

57 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

56 2012 Group Worldwide Chairman

Paulus Stoffels

53 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

56 2012 Vice President, General Counsel

Peter Fasolo

52 2010 Vice President - Global Human Resources

Anne Mulcahy

62 2012 Lead Independent Director

D. Scott Davis

63 2014 Director

Mary Sue Coleman

71 2003 Independent Director

Ian Davis

64 2010 Independent Director

Susan Lindquist

65 2004 Independent Director

Mark McClellan

51 2013 Independent Director

William Perez

67 2007 Independent Director

Charles Prince

65 2006 Independent Director

A. Eugene Washington

64 2012 Independent Director

Ronald Williams

65 2011 Independent Director

Louise Mehrotra

2013 Vice President, Investor Relations
Search Stocks